BioAro Launches PanOmiQ™ Research in UAE Breakthrough for AI-Powered Drug Discovery and Precision Genomics
AI meets multi-omics to revolutionize healthcare from Dubai to the world. DUBAI, UAE – June 2025 — BioAro Inc., a leading Canadian biotechnology and precision medicine company, has officially introduced its groundbreaking PanOmiQ™ Research platform to the UAE market—signaling a new era for AI-integrated genomics and drug discovery across the Middle East and beyond. Unveiled … Read more